Services Offered

One-Step, Rapid
Clinical Solutions

We provide a quick turnaround, offering actionable results to guide Rapid Precision Medicine™ and improve patient outcomes.

magnifying glass over a DNA helix

Phenotype-Driven Results

Rapid, robust phenotype-driven results are delivered to inform medical management

Actionable Next Steps

We expedite disease-specific molecular diagnoses in time to make a clinical difference.

icon of doctors with speech bubbles

Expert Clinical Support

We equip clinicians with insights on evidence-based intervention options.

Turn-Around Times Tailored to Your Patient's Needs

Every minute matters when a child is struggling to survive. We identify or rule out the root causes of genetic disorders in record time.
See time to provisional positive report delivery below.

Ultra-rapid Whole Genome Sequencing

< 3

Calendar Days
Preliminary Report

Rapid Whole
Genome Sequencing

< 5

Business Days
Preliminary Report

Whole Genome
Sequencing

< 30

Business Days

Tests Offered

Ultra-rapid Whole
Genome
Sequencing
Rapid Whole
Genome
Sequencing
Proband Only
Rapid Whole
Genome
Sequencing Duo
Rapid Whole
Genome
Sequencing Trio
Standard/DxO
Whole Genome
Sequencing
Proband Only
Standard/DxO
Whole Genome
Sequencing Trio
Standard/DxO
Whole Genome
Sequencing
Additional Family
Member
Test Type urWGS rWGSP rWGSD rWGST WGSP WGST WGS Additional
Family Member
Preliminary Positive Report
TAT (days)
≤ 3 days ≤ 5 days ≤ 5 days ≤ 5 days N/A N/A N/A
Days to Final Report ≤ 14 days ≤ 14 days ≤ 14 days ≤ 14 days Less than 30 days Less than 30 days Less than 30
days
Samples Required From Patient Patient Patient
One Family
Member
Patient
Two Family
Members
Patient Patient
two Family
Members
One Family
Member

For full test specifications go to Clinicians Toolbox

 Compared to the standard of
what’s available elsewhere,
this is light years fast.”

— Jason Knight, MD,
Medical Director- PICU
CHOC Children’s Hospital of Orange County

Compare Our Comprehensive Diagnostic Solution

TEST TAT SNVs & INDELS CNVs (1 kb)
ANEUPLOIDY
MITOCHONDRIAL SMA
RCIGM Ultra-rapid WGS <3 days* SMN1 & SMN2 Copy Number
Analysis
RCIGM Rapid WGS <5 days* SMN1 & SMN2 Copy Number
Analysis
Commercial Lab Rapid WGS 1-2 weeks Limited
Chromosomal Microarray 1-2 weeks Limited
Targeted Gene Panel 4-6 weeks Limited mDNA panel SMA panel

*Time to provisional, positive report      SNV – single nucleotide variant        CNV – copy number variant    Indel – small insertion/deletion

Frequently Asked Questions

rWGS® is best considered for critically-ill infants and children in the inpatient setting for which a rapid genetic diagnosis could impact medical management and outcomes.

Indications for rWGS® testing include:

  • Critically-ill infants and children in the intensive care unit with no unifying diagnosis
  • Critically-ill infants and children for whom a rapid molecular diagnosis may inform medical management, treatment and/or prognosis
  • Molecular diagnosis of suspected genetic disease
    Identification of rare genetic disease variants in patients who have failed to receive a diagnosis despite extensive work-up and previous testing
  • Infants and children with a history of multiple hospitalizations or readmission within 30 days of discharge for an unexplained condition
  • Infants or children with prolonged hospital stay

Benign and Likely Benign variants are not reported. In addition, RCIGM-CGC does not offer reporting on carrier status, pharmacogenetic markers, polygenic risk scores, or genome wide association studies (GWAS) risk variants.

Questions About Our Tests?

Our Business Development team is here to answer your questions